CA 50 PANCREATIC CANCER MARKER
CA 50 PANCREATIC CANCER MARKER

CA 50 determination by the immunoradiometric assay was compared with the RIA inhibition test in 70 of the patients with pancreatic cancer and in 64 patients with benign diseases. The sensitivity of the CA 50 RIA assay for pancreatic cancer was 69 % and the specificity 56 %

Sample Type - Blood

Reporting Time - 1 Day

Prerequisites - No special preparation required

Price - ₹2300/-

Add to cart Go Home